Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
CDDO-Me | Cell Signaling Technology
Synthesis, Biological Evaluation, and Molecular Docking Study of 3-Amino and 3-Hydroxy-seco A Derivatives of α-Amyrin and 3-Epilupeol as Inhibitors of COX-2 Activity and NF-kB Activation | Journal of Natural Products
Role of NF-κB, PI3K and AKT pathways in ASC-mediated... | Download Scientific Diagram
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites | Journal of Medicinal Chemistry
Bardoxolone (CDDO) | Keap1-Nrf2 Activator | MedChemExpress
APExBIO - Bardoxolone methyl|IKK inhibitor, potent antioxidant inflammation modulator|CAS# 218600-53-4
NF‐κB signaling in inflammation and cancer - Zhang - 2021 - MedComm - Wiley Online Library
Frontiers | Bardoxolone Methyl Ameliorates Compression-Induced Oxidative Stress Damage of Nucleus Pulposus Cells and Intervertebral Disc Degeneration Ex Vivo
IJMS | Free Full-Text | Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
Bardoxolone Methyl | ≥99%(HPLC) | Selleck | IκB/IKK 阻害剤
Bardoxolone methyl - Wikipedia
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy
BARDOXOLONE METHYL
Bardoxolone methyl (RTA 402) | ≥99%(HPLC) | IκB/IKK inhibitor | AdooQ®
Bardoxolone methyl (RTA 402) | Nrf2 Activator | MedChemExpress
Bardoxolone methyl | 218600-53-4
Bardoxolone in Alport Syndrome: The CARDINAL trial — NephJC
NF-kB Signaling Pathway products from Selleck Chemicals
Bardoxolone - an overview | ScienceDirect Topics
Figure 2 from Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Semantic Scholar
Bardoxolone methyl: drug development for diabetic kidney disease | Clinical and Experimental Nephrology
Bardoxolone methyl breaks the vicious cycle between M1 macrophages and senescent nucleus pulposus cells through the Nrf2/STING/NF-κB pathway - ScienceDirect
Bardoxolone methyl: drug development for diabetic kidney disease | Clinical and Experimental Nephrology
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect
